PerkinElmer Sells Medical Imaging Business for $276M

Dec 22, 2016

|

This article has been corrected to reflect the correct acquisition amount.

NEW YORK (GenomeWeb) – PerkinElmer has sold its medical imaging business to Varian Medical Systems for $276 million, the company said in a filing with the US Securities and Exchange Commission today.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Free of Influence

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

Avoiding the MARCH1 to 1-Mar Change

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

Nature Papers Reveal Tuatara Genome, Cell Populations Involved in Lupus

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

Overlooked Expertise

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.

Aug

13

Featured Webinar

Single-Cell and Spatial Transcriptomic Profiling of the Septic Kidney

This webinar will discuss a study that combined single-cell gene expression and spatial gene expression to understand the evolution of sepsis in the kidney at the cellular and molecular level.

Menu

PerkinElmer Sells Medical Imaging Business for $276M

To read the full story....

Breaking News

Fluidigm Q2 Revenues Fall 8 Percent

NantHealth Q2 Revenues Decline 12 Percent

Twist Bioscience Q3 Revenues Grow 56 percent

Guardant Health Q2 Revenues Rise 23 Percent

Illumina Q2 Revenues Drop 25 Percent

Personalis Q2 Revenues Up 23 Percent